bioRxiv Science⌕ Search

Biology subjects

Puisieux, F.

Publications and source records attributed to Puisieux, F..

2 recordsLinked to original sources

Sensorimotor Impairment in Ageing and Neurocognitive Disorders: Beat Synchronisation and Adaptation to Tempo Changes

BackgroundUnderstanding the nature and extent of sensorimotor decline in ageing individuals and those with neurocognitive disorders NCD, such as Alzheimers disease, is essential for designing effective music-based interventions. ObjectiveOur understanding of rhythmic functions remains incomplete, particularly in how ageing and NCD affect sensorimotor synchronisation and adaptation to tempo changes. This study aims to fill this knowledge gap. MethodsPatients from a memory clinic participated in a tapping task, synchronising with metronomic and musical sequences, some of which contained sudden tempo changes. After exclusions, 51 patients were included in the final analysis. ResultsParticipants mini-mental state examination scores were associated with tapping consistency. Additionally, age negatively influenced consistency when synchronising with a musical beat, whereas consistency remained stable across age when tapping with a metronome. ConclusionsThe ability to extract a beat from a musical signal diminishes with age, whereas the capacity to maintain a beat remains relatively constant. However, both processes may decline at moderate or severe stages of NCD. Moreover, the results indicate that the initial decline of attention and working memory with age may impact perception and synchronisation to a musical beat, whereas progressive NCD-related cognitive decline results in more widespread sensorimotor decline, affecting tapping irrespective of audio type. These findings underline the importance of customising rhythm-based interventions to the needs of older adults and individuals with NCD, taking into consideration their cognitive as well as their rhythmic aptitudes. This study was registered at clinicaltrials.gov (NCT04146688).

neuroscience↗

Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection

We quantified S1-specific IgG, neutralizing antibody titers, specific IFN{gamma} secreting T cells and functionality of specific CD4+ and CD8+ T cells in 130 young adults (median age 44.0 years) and 106 older residents living in a long-term care facility (86.5 years) after 2 doses of BNT162b2. Three months after the first injection, humoral and cellular memory responses were dramatically impaired in the 54 COVID-19-naive older compared to the 121 COVID-19-naive younger adults. Notably, older participants neutralizing antibodies, detected in 76.5% (versus 100% in young adults, P < 0.0001), were ten times lower than the youngers antibody titers (P < 0.0001). Antibody and T cell responses were greater among the 52 COVID-19-recovered than among the 54 COVID-19-naive older adults (P < 0.0001). Our study shows that 2 doses of BNT162b2 does not guarantee long-term protection against SARS-CoV-2 in the older. An additional dose should be considered to boost their specific memory response.

immunology↗